Clinical Trials Browser

Phase 2 × Salivary Gland Neoplasms × camrelizumab × Clear all

NCT06145308 2026-04-02

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Phase 2 Recruiting

Salivary Gland Neoplasms